Qing Song Health Co.,Ltd. (TPEX: 6931)
Taiwan
· Delayed Price · Currency is TWD 101.50
-0.50 (-0.49%)
Oct 11, 2024, 2:59 PM CST
Qing Song Health Co.,Ltd. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 932.34 | 868.66 | 636.69 | 357.54 | 240.24 | 124.5 |
| Revenue Growth (YoY) | 19.49% | 36.43% | 78.08% | 48.83% | 92.97% | - |
| Cost of Revenue | 808.09 | 753.65 | 571.12 | 330.73 | 185.13 | 79.18 |
| Gross Profit | 124.24 | 115.02 | 65.57 | 26.81 | 55.11 | 45.32 |
| Selling, General & Admin | 66.55 | 61.11 | 51.66 | 31.54 | 22.72 | 14.68 |
| Research & Development | - | - | - | - | 3.18 | 8.54 |
| Other Operating Expenses | 0.08 | 0.08 | -0.41 | -0.72 | 0.33 | - |
| Operating Expenses | 66.94 | 61.5 | 51.25 | 30.79 | 26.26 | 23.22 |
| Operating Income | 57.31 | 53.52 | 14.32 | -3.98 | 28.85 | 22.1 |
| Interest Expense | -20.93 | -17.64 | -14 | -11.3 | -11.21 | -9.45 |
| Interest & Investment Income | 4.06 | 3.16 | 0.8 | 0.59 | 0.67 | 0.23 |
| Earnings From Equity Investments | - | - | - | -0.16 | -0.23 | -0.27 |
| Other Non Operating Income (Expenses) | 35.34 | 37.37 | 26.5 | 12.99 | 3.24 | 3.25 |
| EBT Excluding Unusual Items | 75.77 | 76.42 | 27.61 | -1.87 | 21.33 | 15.85 |
| Gain (Loss) on Sale of Investments | -1.43 | 3.69 | -1.05 | 0.04 | - | - |
| Gain (Loss) on Sale of Assets | -0.61 | -0.97 | -0.29 | 0.01 | 0.1 | - |
| Other Unusual Items | - | - | 1.22 | 1.46 | 1.03 | - |
| Pretax Income | 73.73 | 79.14 | 27.5 | -0.36 | 22.46 | 15.85 |
| Income Tax Expense | 22.22 | 20.31 | 8.98 | -0.58 | 6.44 | 3.35 |
| Earnings From Continuing Operations | 51.51 | 58.83 | 18.52 | 0.22 | 16.01 | 12.5 |
| Minority Interest in Earnings | 0.38 | 0.57 | 4.81 | -2.18 | -0.17 | 0.31 |
| Net Income | 51.89 | 59.4 | 23.33 | -1.97 | 15.84 | 12.8 |
| Net Income to Common | 51.89 | 59.4 | 23.33 | -1.97 | 15.84 | 12.8 |
| Net Income Growth | 33.87% | 154.61% | - | - | 23.73% | - |
| Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 52 | 36 |
| Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 52 | 36 |
| Shares Change (YoY) | 0.01% | 0.01% | 0.01% | 15.91% | 44.86% | - |
| EPS (Basic) | 0.86 | 0.99 | 0.39 | -0.03 | 0.31 | 0.36 |
| EPS (Diluted) | 0.86 | 0.99 | 0.39 | -0.04 | 0.31 | 0.36 |
| EPS Growth | 35.00% | 156.24% | - | - | -14.33% | - |
| Free Cash Flow | 89.52 | -23.16 | 34.85 | 13.83 | -60.18 | 38.91 |
| Free Cash Flow Per Share | 1.49 | -0.39 | 0.58 | 0.23 | -1.16 | 1.09 |
| Dividend Per Share | 0.083 | 0.083 | - | - | - | - |
| Gross Margin | 13.33% | 13.24% | 10.30% | 7.50% | 22.94% | 36.40% |
| Operating Margin | 6.15% | 6.16% | 2.25% | -1.11% | 12.01% | 17.75% |
| Profit Margin | 5.57% | 6.84% | 3.66% | -0.55% | 6.59% | 10.28% |
| Free Cash Flow Margin | 9.60% | -2.67% | 5.47% | 3.87% | -25.05% | 31.25% |
| EBITDA | 114.37 | 109.43 | 67.77 | 38.37 | 47.81 | 38.75 |
| EBITDA Margin | 12.27% | 12.60% | 10.64% | 10.73% | 19.90% | 31.12% |
| D&A For EBITDA | 57.07 | 55.91 | 53.45 | 42.35 | 18.95 | 16.65 |
| EBIT | 57.31 | 53.52 | 14.32 | -3.98 | 28.85 | 22.1 |
| EBIT Margin | 6.15% | 6.16% | 2.25% | -1.11% | 12.01% | 17.75% |
| Effective Tax Rate | 30.14% | 25.66% | 32.64% | - | 28.69% | 21.16% |
Source: S&P Capital IQ. Standard template. Financial Sources.